Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil vs Gemcitabine Combined With Cisplatin and JS001 in First-line Metastatic Nasopharyngeal Carcinoma
NCT04890522Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluorouracil in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
fluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04890522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890522.